Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Watanabe

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Thoracic Cancer|September 7, 2020
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancerSeigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology-Systemic Combination TherapySusumu Maruta, Yohei Koshima, Yuji Debari, et al.
Canadian Respiratory Journal|December 10, 2021
Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung DiseasesYoichi Tagami, Yu Hara, Kota Murohashi, et al.
Scientific Reports|December 19, 2023
Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung diseaseYoichi Tagami, Yu Hara, Kota Murohashi, et al.
Cancer Science|July 9, 2010
Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: a report from the BINGO studyYuichi Ishikawa, Hitoshi Kiyoi, Keisuke Watanabe, et al.
International Journal of Hematology|December 25, 2012
Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound ironTatsunori Goto, Katsuya Ikuta, Yoshihiro Inamoto, et al.
JCI Insight|April 6, 2018
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenovirusesKeisuke Watanabe, Yanping Luo, Tong Da, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 9, 2020
Decreased Muscle Strength of Knee Flexors is Associated with Impaired Muscle Insulin Sensitivity in Non-Diabetic Middle-Aged Japanese Male SubjectsYuki Someya, Yoshifumi Tamura, Kageumi Takeno, et al.
Nagoya Journal of Medical Science|October 13, 2023
＜Editors' Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumoniaYuki Kata, Yu Hara, Kota Murohashi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2025
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907)Yuki Kojima, Keisuke Watanabe, Motoko Arakaki, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Thoracic Cancer|September 7, 2020
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancerSeigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology-Systemic Combination TherapySusumu Maruta, Yohei Koshima, Yuji Debari, et al.
Canadian Respiratory Journal|December 10, 2021
Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung DiseasesYoichi Tagami, Yu Hara, Kota Murohashi, et al.
Scientific Reports|December 19, 2023
Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung diseaseYoichi Tagami, Yu Hara, Kota Murohashi, et al.
Cancer Science|July 9, 2010
Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: a report from the BINGO studyYuichi Ishikawa, Hitoshi Kiyoi, Keisuke Watanabe, et al.
International Journal of Hematology|December 25, 2012
Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound ironTatsunori Goto, Katsuya Ikuta, Yoshihiro Inamoto, et al.
JCI Insight|April 6, 2018
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenovirusesKeisuke Watanabe, Yanping Luo, Tong Da, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 9, 2020
Decreased Muscle Strength of Knee Flexors is Associated with Impaired Muscle Insulin Sensitivity in Non-Diabetic Middle-Aged Japanese Male SubjectsYuki Someya, Yoshifumi Tamura, Kageumi Takeno, et al.
Nagoya Journal of Medical Science|October 13, 2023
＜Editors' Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumoniaYuki Kata, Yu Hara, Kota Murohashi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2025
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907)Yuki Kojima, Keisuke Watanabe, Motoko Arakaki, et al.
Pageof 23